组织学参数与戒酒决定酒精性肝病患者的长期预后
该研究回顾性分析了192例经活检证实的酒精性肝病患者,其中早期/代偿期60例、失代偿期132例,采用Cox回归模型评估临床、生化及组织学参数对长期预后的影响。早期/代偿期患者5年肝病相关死亡率为13%,失代偿期为43%;纤维化分期是早期/代偿期患者长期生存的主要预测因素,而失代偿期患者的生存则由临床、生化及组织学参数共同预测。戒酒在两组中均为生存的重要预测因素。
要点
- 早期/代偿期酒精性肝病患者中,严重纤维化(F3/4)占52%,10年死亡率F3/4为45% vs F0-2为0%(p<0.001)。
- 5年肝病相关死亡率早期/代偿期为13%,失代偿期为43%。
- 戒酒是早期/代偿期和失代偿期酒精性肝病患者生存的重要预测因素。
核心结论
- 纤维化分期是早期/代偿期酒精性肝病患者长期生存的主要预测因素。
- 失代偿期酒精性肝病患者的生存由临床、生化及组织学参数共同预测。
- 促进戒酒可能改善早期和晚期酒精性肝病患者的生存。
研究设计与样本
- 回顾性分析连续192例经活检证实的酒精滥用所致肝病患者。
- 早期/代偿期酒精性肝病60例,失代偿期酒精性肝病132例(入组时临床失代偿和/或胆红素>3mg/dl)。
- 采用Cox回归模型识别预测长期生存的因素。
主要发现
- 5年肝病相关死亡率早期/代偿期为13%,失代偿期为43%。
- 早期/代偿期患者长期预后由纤维化分期决定,而非临床或生化变量。
- 严重纤维化(F3/4)存在于52%的早期/代偿期患者,10年死亡率F3/4为45% vs F0-2为0%(p<0.001)。
- 失代偿期患者中,临床特征(性别)、肝衰竭生化标志物(胆红素、国际标准化比值[INR])及组织学特征(细胞周围纤维化)共同预测长期生存。
- 随访期间戒酒是早期/代偿期和失代偿期酒精性肝病患者生存的重要预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Few data exist on predictors of long-term prognosis in patients with alcoholic liver disease (ALD). Most studies have only assessed short-term prognosis in patients with advanced ALD. We aimed to assess the prognostic impact of clinical, biochemical and histological parameters on long-term prognosis in patients with early/compensated and decompensated ALD. METHODS: Consecutive patients (n=192) with biopsy-proven liver disease due to alcohol abuse were analyzed retrospectively. Prognostic factors were evaluated in patients with early/compensated ALD (n=60) and in patients with decompensated ALD (clinical decompensation and/or bilirubin >3mg/dl at entry) (n=132). Factors that predict long-term survival were identified using Cox regression models. RESULTS: Liver-related mortality at 5years was 13% in early/compensated and 43% in decompensated ALD. In early/compensated ALD patients, long-term prognosis was determined by fibrosis stage, but not by clinical or biochemical variables. Severe fibrosis (F3/4) was present in 52% and had a major impact on 10-year mortality (F3/4: 45% vs. F0-2: 0%, p<0.001). In contrast, in decompensated patients, a combination of clinical features (sex), biochemical markers of liver failure (bilirubin, international normalized ratio [INR]), and histological features (pericellular fibrosis) predicted long-term survival. During follow-up, abstinence from alcohol was an important predictor of survival in both early/compensated and decompensated ALD. CONCLUSION: Fibrosis stage is the main predictor of long-term survival in patients with early/compensated ALD, while clinical, biochemical and histological parameters predict survival in patients with decompensated disease. Promoting abstinence may improve survival in patients with both early and advanced ALD. LAY SUMMARY: In this study, we evaluated long-term outcome in 192 patients with alcoholic liver disease who underwent liver biopsy: 60 patients with early disease (no symptoms) and 132 patients with advanced disease (jaundice, complications of cirrhosis). Importantly, half of the patients with 'early' disease already had severe fibrosis or cirrhosis on liver histology and dismal outcome (45% mortality at 10years). Abstinence from alcohol improved the prognosis in both early and advanced stages of the disease.
引用
- Lackner C, Spindelboeck W, Haybaeck J, et al. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol. 2016. PMID: 27894795. doi:10.1016/j.jhep.2016.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。